Portfolio company
Altay Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
Deep TechDigital Health
About
This company develops small molecule drugs targeting transcription factors to treat patients with facioscapulohumeral muscular dystrophy, chronic liver diseases and various cancers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.